These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 32960931)
1. The glucosyltransferase activity of C. difficile Toxin B is required for disease pathogenesis. Bilverstone TW; Garland M; Cave RJ; Kelly ML; Tholen M; Bouley DM; Kaye P; Minton NP; Bogyo M; Kuehne SA; Melnyk RA PLoS Pathog; 2020 Sep; 16(9):e1008852. PubMed ID: 32960931 [TBL] [Abstract][Full Text] [Related]
2. Glucosyltransferase-dependent and independent effects of Clostridioides difficile toxins during infection. Peritore-Galve FC; Shupe JA; Cave RJ; Childress KO; Washington MK; Kuehne SA; Lacy DB PLoS Pathog; 2022 Feb; 18(2):e1010323. PubMed ID: 35176123 [TBL] [Abstract][Full Text] [Related]
7. Analysis of TcdB Proteins within the Hypervirulent Clade 2 Reveals an Impact of RhoA Glucosylation on Clostridium difficile Proinflammatory Activities. Quesada-Gómez C; López-Ureña D; Chumbler N; Kroh HK; Castro-Peña C; Rodríguez C; Orozco-Aguilar J; González-Camacho S; Rucavado A; Guzmán-Verri C; Lawley TD; Lacy DB; Chaves-Olarte E Infect Immun; 2016 Jan; 84(3):856-65. PubMed ID: 26755157 [TBL] [Abstract][Full Text] [Related]
8. Cytotoxicity of Clostridium difficile toxin B does not require cysteine protease-mediated autocleavage and release of the glucosyltransferase domain into the host cell cytosol. Li S; Shi L; Yang Z; Feng H Pathog Dis; 2013 Feb; 67(1):11-8. PubMed ID: 23620115 [TBL] [Abstract][Full Text] [Related]
9. Defining the Roles of TcdA and TcdB in Localized Gastrointestinal Disease, Systemic Organ Damage, and the Host Response during Clostridium difficile Infections. Carter GP; Chakravorty A; Pham Nguyen TA; Mileto S; Schreiber F; Li L; Howarth P; Clare S; Cunningham B; Sambol SP; Cheknis A; Figueroa I; Johnson S; Gerding D; Rood JI; Dougan G; Lawley TD; Lyras D mBio; 2015 Jun; 6(3):e00551. PubMed ID: 26037121 [TBL] [Abstract][Full Text] [Related]
10. The role of purified Clostridium difficile glucosylating toxins in disease pathogenesis utilizing a murine cecum injection model. Zhang Y; Yang Z; Gao S; Hamza T; Yfantis HG; Lipsky M; Feng H Anaerobe; 2017 Dec; 48():249-256. PubMed ID: 29031928 [TBL] [Abstract][Full Text] [Related]
12. Structural determinants of Clostridium difficile toxin A glucosyltransferase activity. Pruitt RN; Chumbler NM; Rutherford SA; Farrow MA; Friedman DB; Spiller B; Lacy DB J Biol Chem; 2012 Mar; 287(11):8013-20. PubMed ID: 22267739 [TBL] [Abstract][Full Text] [Related]
13. A chimeric toxin vaccine protects against primary and recurrent Clostridium difficile infection. Wang H; Sun X; Zhang Y; Li S; Chen K; Shi L; Nie W; Kumar R; Tzipori S; Wang J; Savidge T; Feng H Infect Immun; 2012 Aug; 80(8):2678-88. PubMed ID: 22615245 [TBL] [Abstract][Full Text] [Related]
14. Development of an Effective Nontoxigenic Clostridioides difficile-Based Oral Vaccine against C. difficile Infection. Wang S; Zhu D; Sun X Microbiol Spectr; 2022 Jun; 10(3):e0026322. PubMed ID: 35583336 [TBL] [Abstract][Full Text] [Related]
15. Toxin B is essential for virulence of Clostridium difficile. Lyras D; O'Connor JR; Howarth PM; Sambol SP; Carter GP; Phumoonna T; Poon R; Adams V; Vedantam G; Johnson S; Gerding DN; Rood JI Nature; 2009 Apr; 458(7242):1176-9. PubMed ID: 19252482 [TBL] [Abstract][Full Text] [Related]
16. Autocatalytic processing of Clostridium difficile toxin B. Binding of inositol hexakisphosphate. Egerer M; Giesemann T; Herrmann C; Aktories K J Biol Chem; 2009 Feb; 284(6):3389-95. PubMed ID: 19047051 [TBL] [Abstract][Full Text] [Related]
17. TcdB of Stieglitz F; Gerhard R; Hönig R; Giehl K; Pich A Int J Mol Sci; 2022 Apr; 23(8):. PubMed ID: 35457076 [TBL] [Abstract][Full Text] [Related]
18. Identification of the role of toxin B in the virulence of Clostridioides difficile based on integrated bioinformatics analyses. Gao Y; Gao W; Cheng J; Ma L; Su J Int Microbiol; 2020 Nov; 23(4):575-587. PubMed ID: 32388701 [TBL] [Abstract][Full Text] [Related]
19. The Importance of Therapeutically Targeting the Binary Toxin from Abeyawardhane DL; Godoy-Ruiz R; Adipietro KA; Varney KM; Rustandi RR; Pozharski E; Weber DJ Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33805767 [TBL] [Abstract][Full Text] [Related]
20. Glucosyltransferase activity of Clostridium difficile Toxin B is essential for disease pathogenesis. Yang Z; Zhang Y; Huang T; Feng H Gut Microbes; 2015 Jul; 6(4):221-4. PubMed ID: 26091306 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]